August 16-22, 2010
Vail Marriott Mountain Resort & Spa
Vail, Colorado
Karl Kieburtz, MD, MPH
Karl Kieburtz, MD, MPH, is Professor of Neurology, Community and Preventive Medicine, Environmental Medicine and the
Director of the Center for Human Experimental Therapeutics at the University of Rochester Medical Center in Rochester,
New York. He is helping to develop a T1 Key Function for the Rochester Clinical Translational Science Institute. His
primary clinical and research interests are neurodegenerative diseases affecting the basal ganglia, particularly Parkinson
disease, Huntington disease, and HIV related neurologic disorders. He is the principal investigator for the NINDS sponsored
trials of neuroprotective agents for PD (NET-PD) and currently chairs the Executive Committee of the Parkinson Study Group.
He also directs the Coordination Center for other NIH and foundation supported multi-center academic consortia.
APPLICATIONS DUE BY 3/26/2010
ACCEPTED PARTICIPANTS WILL RECEIVE FULL SCHOLARSHIPS FOR TUITION AND EXPENSES
|
Supported by the National Institute of Neurological Disorders and Stroke |
|